Pharmacotherapeutics of SARS-CoV-2 Infections

The COVID-19 pandemic has affected more than 38 million people world-wide by person to person transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therapeutic and preventative strategies for SARS-CoV-2 remains a significant challenge. Within the past several months, effe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Neuroimmune Pharmacol
Autores principales: Kevadiya, Bhavesh D., Machhi, Jatin, Herskovitz, Jonathan, Oleynikov, Maxim D., Blomberg, Wilson R., Bajwa, Neha, Soni, Dhruvkumar, Das, Srijanee, Hasan, Mahmudul, Patel, Milankumar, Senan, Ahmed M., Gorantla, Santhi, McMillan, JoEllyn, Edagwa, Benson, Eisenberg, Robert, Gurumurthy, Channabasavaiah B., Reid, St Patrick M., Punyadeera, Chamindie, Chang, Linda, Gendelman, Howard E.
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer US 2021
Materias:
Invited Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7785334/
https://ncbi.nlm.nih.gov/pubmed/33403500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11481-020-09968-x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares